# The 1 –Cys peroxiredoxin, PRDX-6, suppresses an NHR-49-dependent pro-survival response, including the Flavin monooxygenase, FMO-2, that protects against fungal and bacterial infection

**Authors:** Emma L. Button, Emilia Dwyer, Jake B. Lewis, Madison S. Mortensen, Elise McDonald, Eloise Butler, Fiona Pearson, Alice E. Tang, Jennifer L. Watts, Elizabeth A. Veal

PMC · DOI: 10.1016/j.redox.2025.103992 · Redox Biology · 2025-12-29

## TL;DR

The study shows that the protein PRDX-6 in worms influences lifespan, immunity, and stress resistance by regulating other genes like FMO-2 and NHR-49.

## Contribution

The paper reveals a novel protective role of NHR-49-dependent FMO-2 in prdx-6 mutants against infection and stress.

## Key findings

- Loss of PRDX-6 increases lifespan and resistance to arsenite and pathogens in C. elegans.
- PRDX-6 loss leads to increased NHR-49 activity and FMO-2 expression, which protects against infection.
- NHR-49-driven MUFA synthesis is essential for embryonic development in prdx-6 mutants.

## Abstract

Reactive oxygen species (ROS)-induced cell damage contributes to many diseases. However, ROS also contribute to cell signaling and immune defences. As ubiquitous thiol peroxidases, peroxiredoxins (Prdx) play integral roles in balancing ROS functions. High levels of Prdx6 are associated with increased metastasis and resistance to chemotherapy, rendering Prdx6 a therapeutic target for treatment of a broad range of cancers. However, Prdx6 has additional activities, in lipid signaling and selenocysteine metabolism, and it remains unclear how Prdx6's thiol peroxidase activity contributes to disease. Here we have investigated the role/s of Prdx6 in the nematode worm Caenorhabditis elegans. Consistent with a ROS-protective role for PRDX-6, prdx-6 mutant C. elegans exhibit elevated levels of lipid oxidation, more apoptotic corpses in their germline and are more susceptible to the toxicity of diethyl maleate. However, unexpectedly, prdx-6 mutant C. elegans are more resistant to other forms of oxidative stress, long-lived and resistant to infection with two opportunistic human pathogens; the gram-positive bacteria Staphylococcus aureus and the dimorphic yeast Candida albicans. Our data suggest these phenotypes are associated with increased activity of the NHR-49(PPARα/HNF4) transcriptional regulator and intestinal expression of the Flavin monooxygenase, FMO-2. FMO-2 has a conserved, pro-survival function and is up-regulated in response to various stresses, including peroxides and S. aureus infection. Here we reveal that fmo-2 expression is also increased as an NHR-49-dependent protective response to C. albicans. Consistent with increased NHR-49 activity, prdx-6 mutant animals also contain increased levels of mono-unsaturated fatty acids. Accordingly, we propose that elevated expression of fmo-2 and other NHR-49 up-regulated genes contribute to the increased arsenite resistance and innate immunity of prdx-6 mutant animals. These findings further illustrate the complex roles that ROS, PRDX and lipid oxidation can play in oxidative stress resistance, immunity and ageing.

Image 1

•PRDX-6 protects against lipid hydroperoxides, germ cell apoptosis and DEM toxicity.•Loss of PRDX-6 increases lifespan, arsenite resistance and innate immunity of C. elegans.•Loss of PRDX-6, bacterial and fungal infection all increase NHR-49-dependent expression of the flavin monooxygenase fmo-2.•FMO-2 protects against infection and is important for the effects of prdx-6 on arsenite resistance and ageing.•NHR-49-driven increased MUFA synthesis is required for the embryonic development of prdx-6 mutant C.
elegans.

PRDX-6 protects against lipid hydroperoxides, germ cell apoptosis and DEM toxicity.

Loss of PRDX-6 increases lifespan, arsenite resistance and innate immunity of C. elegans.

Loss of PRDX-6, bacterial and fungal infection all increase NHR-49-dependent expression of the flavin monooxygenase fmo-2.

FMO-2 protects against infection and is important for the effects of prdx-6 on arsenite resistance and ageing.

NHR-49-driven increased MUFA synthesis is required for the embryonic development of prdx-6 mutant C.
elegans.

## Linked entities

- **Genes:** PRDX6 (peroxiredoxin 6) [NCBI Gene 9588], nhr-49 (NR LBD domain-containing protein;Nuclear hormone receptor family member nhr-49) [NCBI Gene 172839], FMO2 (flavin containing dimethylaniline monoxygenase 2) [NCBI Gene 2327]
- **Proteins:** PRDX6 (peroxiredoxin 6), FMO2 (flavin containing dimethylaniline monoxygenase 2), nhr-49 (NR LBD domain-containing protein;Nuclear hormone receptor family member nhr-49)
- **Chemicals:** diethyl maleate (PubChem CID 5271566), arsenite (PubChem CID 544)
- **Species:** Caenorhabditis elegans (taxon 6239), Staphylococcus aureus (taxon 1280), Candida albicans (taxon 5476)

## Full-text entities

- **Genes:** nhr-49 (NR LBD domain-containing protein;Nuclear hormone receptor family member nhr-49) [NCBI Gene 172839], gpx-8 (pseudo) [NCBI Gene 172983], gpx-4 (Glutathione peroxidase) [NCBI Gene 190801], prdx-2 (Peroxiredoxin prdx-2) [NCBI Gene 266858], daf-16 (Forkhead box protein O) [NCBI Gene 172981], sod-3 (Superoxide dismutase) [NCBI Gene 181748], PRDX6 (peroxiredoxin 6) [NCBI Gene 9588] {aka 1-Cys, AOP2, HEL-S-128m, LPCAT-5, NSGPx, PRX}, trxr-1 (Thioredoxin reductase 1;thioredoxin-disulfide reductase) [NCBI Gene 177466], prdx-6 (Thioredoxin domain-containing protein) [NCBI Gene 176837], pmk-1 (Mitogen-activated protein kinase pmk-1) [NCBI Gene 191743], lipl-2 (Lipase) [NCBI Gene 185840], gcs-1 (Glutamate--cysteine ligase) [NCBI Gene 174438], tph-1 (Biopterin-dependent aromatic amino acid hydroxylase family profile domain-containing protein) [NCBI Gene 174227], C07E3.9 (Phospholipase A2) [NCBI Gene 182374], hlh-30 (Helix-loop-helix protein 30) [NCBI Gene 177157], cdc-25.1 (M-phase inducer phosphatase cdc-25.1) [NCBI Gene 172353], gst-4 (Glutathione S-transferase 4) [NCBI Gene 177886], lim-7 (LIM/homeobox protein lim-7) [NCBI Gene 172236], prdx-3 (putative peroxiredoxin prdx-3) [NCBI Gene 175573], skn-1 (BZIP domain-containing protein;Protein skinhead-1) [NCBI Gene 177343], fmo-2 (Flavin-containing monooxygenase) [NCBI Gene 177958], ipla-2 (Intracellular phospholipase A2) [NCBI Gene 181196], ced-1 (Cell death abnormality protein 1) [NCBI Gene 173064], rol-6 (Cuticle collagen rol-6) [NCBI Gene 174397]
- **Diseases:** infection (MESH:D007239), cancers (MESH:D009369), toxicity (MESH:D064420), embryonic lethality (MESH:D020964), metastasis (MESH:D009362), Fungal and bacterial infection (MESH:D009181), hypoxia (MESH:D000860), bacterial (MESH:D001424), NSM (MESH:D016472)
- **Chemicals:** sodium arsenite (MESH:C017947), thiol (MESH:D013438), peroxide (MESH:D010545), IGEPAL CA-630 (MESH:C010615), tert-butyl hydroperoxide (MESH:D020122), DEM (MESH:C014476), Fatty acid (MESH:D005227), selenium (MESH:D012643), MUFA (MESH:D005229), lipid hydroperoxides (MESH:D008054), H2DCFDA (MESH:C110400), platinum (MESH:D010984), H2O2 (MESH:D006861), -6and (-), Sodium Chloride (MESH:D012965), methanol (MESH:D000432), TS (MESH:D014316), PUFA (MESH:D005231), hexane (MESH:D006586), DCF (MESH:D015649), Disodium Phosphate (MESH:C018279), lysophosphatidylcholine (MESH:D008244), Oleic acid (MESH:D019301), BODIPY (MESH:C095489), 5'Fluoro-2'-deoxyuridine (MESH:C576827), kanamycin (MESH:D007612), DAPI (MESH:C007293), levamisole (MESH:D007978), sodium oleate (MESH:C013173), Dextrose (MESH:D005947), Arsenite (MESH:C015001), ROS (MESH:D017382), selenocysteine (MESH:D017279), sulfuric acid (MESH:C033158), FAMEs (MESH:C508762), water (MESH:D014867), Nalidixic acid (MESH:D009268), metformin (MESH:D008687), DCFDA (MESH:C029569), Lipid (MESH:D008055), cysteine (MESH:D003545), agarose (MESH:D012685)
- **Species:** Staphylococcus aureus (species) [taxon 1280], Caenorhabditis elegans (species) [taxon 6239], Pseudomonas aeruginosa (species) [taxon 287], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Candida albicans (species) [taxon 5476], Escherichia coli (E. coli, species) [taxon 562], C. elegans [taxon 328850], aureus [taxon 46170], Salmonella enterica subsp. enterica serovar Typhimurium (no rank) [taxon 90371], Enterococcus faecalis (species) [taxon 1351], Cryptococcus neoformans (Cryptococcus neoformans serotype A, species) [taxon 5207]
- **Cell lines:** VE44 — Homo sapiens (Human), Finite cell line (CVCL_ZS72), CL2166 — Homo sapiens (Human), Huntington's disease, Transformed cell line (CVCL_F054), SN148 — Homo sapiens (Human), Galactosemia, Transformed cell line (CVCL_9Q63), VC1668 — Homo sapiens (Human), Transformed cell line (CVCL_9G98), SL1344 — Homo sapiens (Human), Duchenne muscular dystrophy, Induced pluripotent stem cell (CVCL_YQ57), NCTC 8325 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_K271), OP50 — Homo sapiens (Human), q11.2) BCR-ABL1, Cancer cell line (CVCL_DG77)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12930036/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12930036/full.md

## References

79 references — full list in the complete paper: https://tomesphere.com/paper/PMC12930036/full.md

---
Source: https://tomesphere.com/paper/PMC12930036